Reuters logo
BRIEF-Intercept Pharmaceuticals reports Q4 sales $13.8 mln
February 23, 2017 / 1:02 PM / in 8 months

BRIEF-Intercept Pharmaceuticals reports Q4 sales $13.8 mln

Feb 23 (Reuters) - Intercept Pharmaceuticals Inc

* Q4 sales $13.8 million

* Intercept pharmaceuticals reports full year 2016 financial results and provides business update

* Q4 revenue view $9 million -- Thomson Reuters I/B/E/S

* Intercept pharmaceuticals inc sees NON-GAAP adjusted operating expenses of $380 million to $420 million for fiscal year ending december 31, 2017

* Qtrly loss per share $4.84 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below